Cargando…
Enhancement of oxaliplatin-induced colon cancer cell apoptosis by alantolactone, a natural product inducer of ROS
Colon cancer is a malignant type of cancer with high prevalence and is one of the primary causes of cancer-related deaths. Oxaliplatin plays a significant role in the treatment of cancer, but the application of oxaliplatin is restricted due to its toxic side effects and drug resistance in clinical p...
Autores principales: | Cao, Peihai, Xia, Yiqun, He, Wei, Zhang, Tingting, Hong, Lin, Zheng, Peisen, Shen, Xin, Liang, Guang, Cui, Ri, Zou, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643222/ https://www.ncbi.nlm.nih.gov/pubmed/31360110 http://dx.doi.org/10.7150/ijbs.35265 |
Ejemplares similares
-
Curcuminoid WZ35 synergize with cisplatin by inducing ROS production and inhibiting TrxR1 activity in gastric cancer cells
por: He, Wei, et al.
Publicado: (2019) -
Induction of ROS Overload by Alantolactone Prompts Oxidative DNA Damage and Apoptosis in Colorectal Cancer Cells
por: Ding, Yushuang, et al.
Publicado: (2016) -
Aminooxyacetic acid (AOAA) sensitizes colon cancer cells to oxaliplatin via exaggerating apoptosis induced by ROS
por: Yue, Taohua, et al.
Publicado: (2020) -
Targeting Apoptosis Pathways in Cancer with Alantolactone and Isoalantolactone
por: Rasul, Azhar, et al.
Publicado: (2013) -
Combination therapy with HSP90 inhibitors and piperlongumine promotes ROS-mediated ER stress in colon cancer cells
por: Qiu, Chenyu, et al.
Publicado: (2023)